JOHN SIMARD - 31 Jan 2025 Form 4 Insider Report for XBiotech Inc. (XBIT)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: John Simard
Issuer symbol: XBIT
Transactions as of: 31 Jan 2025
Net transactions value: -$24,703,550,000,000
Form type: 4
Filing time: 04 Feb 2025, 16:53:27 UTC
Previous filing: 05 Jan 2024
Next filing: 19 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SIMARD JOHN	Chief Executive Officer, Director, 10%+ Owner	5217 WINNEBAGO LANE, AUSTIN	John Simard	03 Feb 2025	0001639078

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XBIT	Convertible Loan Agreement	Other	$24,703,550,000,000	-2,470,355	-74%	$10000000.00	870,381	31 Jan 2025	Common Shares or Preferred Shares	2,470,335	$4.05	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 31, 2025, the Convertible Loan Agreement (the "Loan") dated as of January 3, 2024 between XBiotech Inc. and John Simard, the Company's Founder, President, Chief Executive Officer, and Chairman, was terminated upon full repayment of the Loan by the Company. As a result, all conversion rights to XBiotech stock associated with the Loan were extinguished.